{"title":"用因子设计法设计和开发消炎药萘普生的固体分散体和制剂","authors":"Taraka Ramarao Challa, Pathivada SaiKiranmai","doi":"10.55766/sujst-2023-06-e01216","DOIUrl":null,"url":null,"abstract":"Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44<F88<F77<F11<F66<F55<F33<F2 depicts the order of released various formulations. The release profiles of F2 and the Naprosyn tablet are similar. These findings suggest that a new naproxen tablet formulation, including the β-Cyclodextrin: Kolliphor - p188 complex, could be a viable alternative for improving oral bioavailability.","PeriodicalId":509211,"journal":{"name":"Suranaree Journal of Science and Technology","volume":"27 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"DESIGN AND DEVELOPMENT OF ANTI-INFLAMMATORY DRUG NAPROXEN SOLID DISPERSIONS AND FORMULATIONS BY FACTORIAL DESIGN APPROACH\",\"authors\":\"Taraka Ramarao Challa, Pathivada SaiKiranmai\",\"doi\":\"10.55766/sujst-2023-06-e01216\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44<F88<F77<F11<F66<F55<F33<F2 depicts the order of released various formulations. The release profiles of F2 and the Naprosyn tablet are similar. These findings suggest that a new naproxen tablet formulation, including the β-Cyclodextrin: Kolliphor - p188 complex, could be a viable alternative for improving oral bioavailability.\",\"PeriodicalId\":509211,\"journal\":{\"name\":\"Suranaree Journal of Science and Technology\",\"volume\":\"27 12\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Suranaree Journal of Science and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55766/sujst-2023-06-e01216\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Suranaree Journal of Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55766/sujst-2023-06-e01216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
DESIGN AND DEVELOPMENT OF ANTI-INFLAMMATORY DRUG NAPROXEN SOLID DISPERSIONS AND FORMULATIONS BY FACTORIAL DESIGN APPROACH
Naproxen is a non-steroidal anti-inflammatory (NSAID) drug that can be used as an analgesic, anti-inflammatory, and antipyretic. Objectives: The study’s major goal was to improve the drug’s solubility and dissolution rate, as well as its oral bioavailability. Methods: Physical mixture, kneading process, and solvent evaporation method were used to make Naproxen solid dispersions (SDs). Using a two-level factorial design and three independent components, X1 β-Cyclodextrin, X2: Kolliphor p-188, and X3: PVPK-30 and designed by a Design expert (DOE). The formulation was studied by flow parameters, physical characteristics, Fourier-transform infrared spectroscopy, and comparative investigations with commercially available Naprosyn and F2. Major Results: In vitro performance of solid dispersions SD’s was favorable (100% drug release 20 minutes), compared to a pure drug, where 100 percent drug release takes 80 minutes. The FTIR spectra of pure drug and combinations with excipients were having no chemical interaction. The F44